U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511218) titled 'A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants' on March 30.
Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability, immunogenicity and Pharmacokinetics (PK) characteristics of AHB-171 Injection in healthy participants (Part A) and participants with chronic hepatitis B (CHB, Part B), and assess its preliminary efficacy in CHB participants.
Study Start Date: April 15
Study Type: INTERVENTIONAL
Condition:
Chronic Hepatitis B Infection
Intervention:
DRUG: AHB-171 Injection
AHB-171 Injection is adminstrated via subcutaneous injection
DR...